相关实验视频

Updated: Jun 16, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

孕期糖尿病妇女的医疗营养治疗:当前的实践和未来的前景

Louisa Cheong¹, Lawrence Siu-Chun Law¹, Li Ying Lyeann Tan¹

¹Division of Endocrinology, Department of Medicine, National University Hospital, Singapore 119074, Singapore.

|April 12, 2025

概括

为孕期糖尿病 (GDM) 优化医疗营养治疗 (MNT) 对母婴健康至关重要. 解决个体需求和营养差距可以改善血糖控制和长期结果.

科学领域:

产科和妇科产科和妇科
内分泌学在内分泌学.
营养科学营养科学

背景情况:

妊娠期糖尿病 (GDM) 影响全球20%的怀孕,对母亲和婴儿的心脏代谢健康构成风险.
目前的GDM管理包括生活方式的改变 (MNT,体力活动) 和药物治疗,但最佳的MNT策略仍然不清楚.
微量营养素缺乏和文化因素会阻碍有效的GDM管理和个性化的营养干预措施.

研究的目的:

审查目前关于优化妊娠糖尿病 (GDM) 医学营养治疗 (MNT) 的证据.
确定阻碍GDM孕妇有效饮食管理的关键障碍.
概述未来的研究重点,以推进GDM护理中的个性化营养.

主要方法:

对GDM的MNT现有证据的文献综述.
分析挑战,包括个体变化,生理变化和饮食习惯.
探索微量营养素和诸如重症的状况对GDM管理的影响.

主要成果:

在确定GDM最佳MNT时存在大量差距,受个人葡萄糖耐受性和不断变化的孕产妇需求的影响.
宏观营养素平衡,碳水化合物质量/分布以及足够的蛋白质/脂肪摄入量对于血糖控制至关重要.
微量营养素状况 (例如,维生素D,) 和文化饮食习惯显著影响GDM结果和坚持.

结论:

个性化的营养干预措施对于优化GDM的MNT至关重要.
解决微量营养素缺乏和文化因素等障碍对于改善母亲和婴儿健康结果至关重要.
需要进一步的研究来推进临床实践,并完善GDM个性化的营养策略.

关键词:

碳水化合物碳水化合物孕期糖尿病孕期糖尿病医疗营养疗法医疗营养疗法

更多相关视频

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

相关概念视频

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...